Ocugen Stock News

Related Stocks: OCGN ,

Ocugen has potential for its gene therapy treatment for eye diseases, but OCGN stock movement has been all about Covaxin.

There was some highly encouraging news about coronavirus vaccines, but not the one the company is associated with.

Cardiff Oncology (NASDAQ:CRDF) and Ocugen (NASDAQ:OCGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, earnings and profitability. Institutional & Insider Ownership 67.0% of Cardiff Oncology shares are owned by institutional investors. Comparatively, 28.5% []

Ocugen has potential for its gene therapy treatment for eye diseases, but OCGN stock movement has been all about Covaxin. The post The Slide in Ocugen Could Be a Slide to a Homerun appeared first on I

Ocugen Inc. (NASDAQ:OCGN)s traded shares stood at 13.91 million during the last session, with the companys beta value hitting 4.65. At the close of trading, the stocks price was $7.26, to imply a decrease of -5.10% or -$0.39 in intraday trading. The OCGN shares 52-week high remains $18.77, putting it -158.54% down since that peak Ocugen Inc. (NASDAQ: OCGN) Shares Fall By -16.46 Percent In The Past Week, But How Long Will It Last? Read More »

Ocugen (NASDAQ:OCGN) and Acumen Pharmaceuticals (NASDAQ:ABOS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Analyst Recommendations This is a summary of current recommendations for Ocugen and Acumen Pharmaceuticals, as provided []

This biotech is targeting a lucrative market, but it may be too late for the company.

But can they keep up the momentum?

Ocugen, Inc. (OCGN) with the stream of -2.11% also noticed, India Roblox Corporation (RBLX) encountered a rapid change of -1.25% in the last hour of Tuesdays trading session. Ocugen, Inc. The post Technical Indicators under Consideration: Ocugen, Inc. (NASDAQ:OCGN), Roblox Corporation (NYSE:RBLX) appeared first on Stocks Equity .

Revenue may not be right around the corner.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips A doomed-looking vaccine partnership puts Ocugen back in the business of obscurity and OCGN stock at risk of much lower prices. The post Ocugen Needs More Than Covaxin to Boost Its Falling Shares appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First

A doomed-looking vaccine partnership puts Ocugen back in the business of obscurity and OCGN stock at risk of much lower prices. The post Ocugen Needs More Than Covaxin to Boost Its Falling Shares appe

In the last trading session, 11.58 million Ocugen Inc. (NASDAQ:OCGN) shares changed hands as the companys beta touched 4.65. With the companys per share price at $8.30 changed hands at -$0.52 or -5.90% during last session, the market valuation stood at $1.63B. OCGNs last price was a discount, traded about -126.14% off its 52-week high An Overview Of Ocugen Inc. (NASDAQ: OCGN) Read More »

Ocugen (NASDAQ:OCGN) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research report issued to clients and investors on Friday, Zacks.com reports. The firm presently has a $9.50 price objective on the stock. Zacks Investment Researchs price objective would suggest a potential upside of 7.71% from the stocks []